Arkolith/Insider Trading/NEXI/Form 4

Roemer Alan S.

DirectorNexImmune, Inc. (NEXI) · full profile →Form 4 · filed Nov 22, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 22, 2023Sell(S)4K$1.94$8K0
Nov 21, 2023Sell(S)4K$2.16$8K4K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-056514) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML